Durvalumab is a medication used to help the immune system detect and fight cancer cells. It works by blocking a specific protein that prevents the immune system from attacking cancer cells, allowing the body to better target and destroy them.

Tremelimumab is another medication that helps the immune system fight cancer. It works by targeting a protein that can suppress the immune response, thereby enhancing the body’s ability to attack cancer cells.

Lenvatinib is a medication that helps slow down the growth of cancer cells. It works by blocking certain proteins that cancer cells need to grow and spread, which can help control the progression of the disease.

Transarterial Chemoembolization (TACE) is a procedure used to treat liver cancer. It involves delivering chemotherapy directly to the liver tumor through the blood vessels, while also blocking the blood supply to the tumor to help shrink it.

Locoregional Hepatocellular Carcinoma (HCC) – This is a type of liver cancer that originates in the liver cells and is confined to the liver and its surrounding region. It typically begins as a single tumor or multiple small tumors within the liver. As the disease progresses, the cancerous cells can invade nearby blood vessels and tissues. The growth of these tumors can lead to liver dysfunction and may cause symptoms such as abdominal pain, weight loss, and jaundice. Over time, the cancer may spread to nearby lymph nodes or other parts of the body. The progression of the disease can vary, with some cases remaining stable for a period before advancing.